Search results
AstraZeneca/Fibrogen’s Roxadustat FDA Review Further Delayed Following Unanticipated Advisory...
Clinical Trials Arena via Yahoo Finance· 1 day agoFDA Delays Decision on AstraZeneca/Fibrogen’s Roxadustat for CKD Anemia On March 1, AstraZeneca and...
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 5 days ago(tralokinumab-ldrm), will gain an alternative mode of administration following a US Food and Drug...
'You're failing!': The federal government is having a reckoning over youth vaping, as senators tear...
Fortune· 6 days agoParticularly, the senators blamed the Food and Drug Administration (FDA) and the Department of Justice (DOJ) for not enforcing the Tobacco Control Act, ...
Takeda drug for rare types of epilepsy misses goal in late-stage trial
BioPharma Dive via Yahoo Finance· 23 hours agoCalled soticlestat, the drug had seemed promising in earlier studies for people with Dravet and...
Senators decry lax e-cig enforcement | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 5 days ago"I simply do not understand how FDA and DOJ have permitted thousands of products to remain on store...
Donanemab’s solid day
Politico· 7 days agoThe announcement came days ahead of a Senate Judiciary Committee hearing...Thus far, our agencies have failed to prevent a wave of youth e-cigarette addiction.” FDA ...
FDA clears Dianthus Therapeutics' Phase 2 MMN drug trial By Investing.com
Investing.com· 6 days agoDianthus Therapeutics, Inc. (NASDAQ:DNTH), a biotech firm, has received FDA clearance for a Phase 2...
North Carolina Democrats praise, Republicans silent on mifepristone
The Center Square· 5 days agoBy limiting the scope considered on the hot-button issue of the Food and Drug Administration’s ...
FDA, DOJ hammered on response to illegal vapes - Roll Call
CQ Politics· 6 days agoSenators from both sides of the aisle took the Food and Drug Administration and Department of...
Elion secures $81m to advance antifungal therapy
Pharmaceutical Technology via Yahoo Finance· 18 hours agoElion’s antifungal therapy SF001 targets aspergillosis, which can be caused by Aspergillus fumigatus, a pathogen of critical priority as per the WHO.
